LONDON, Jan. 14, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
Zacks Investment Research on MSN
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
Viatris VTRS announced the acquisition of Tokyo-based Aculys Pharma, a clinical-stage biopharmaceutical company specializing ...
neffy 1 mg available nationwide for children aged four and older and co-promotion agreement with ALK-Abelló Inc. increases neffy promotional reach to nearly 20,000 healthcare providers, including key ...
The PDUFA date for CARDAMYST™ is set for March 27, 2025, indicating a lengthy approval timeline that could delay commercialization and revenue generation for the company. The reliance on the FDA's ...
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk ...
San Diego’s ARS Pharmaceuticals, which is developing a non-injection nasal spray to combat severe allergic reactions, has inked a reverse merger that would boost its cash stockpile and make it a ...
(WJW) – If it works as billed, a nasal spray for migraines could be life-changing for millions of people who suffer from the debilitating health issue. The U.S. Food and Drug Administration approved a ...
Comedian Nate Bargatze hosted "Saturday Night Live" last season, joking in his opening monologue about being "addicted to Afrin." "If you don’t know what it is, I would honestly tell you to not get ...
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...
Sept. 4, 2025 – A common over-the-counter nasal spray grabbed headlines and social media buzz this week as a simple, surprising way to reduce your chances of getting COVID-19. But is the hype getting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback